Latest News for: dose
Edit
'Dose' OTT release: When and where to watch; Streaming details of Siju Wilson and Jagadish's thriller
The Times of India 08 Jul 2026
Edit
Missoulian
07 Jul 2026
Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose ...
Edit
Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in ...
Nasdaq Globe Newswire 07 Jul 2026
Teva will hold an investor call and live webcast today,. Tuesday, July 7, 2026, at 8.00 a.m. ET to discuss these data ... .
Edit
Killeen Daily Herald
07 Jul 2026
EnteroBiotix Announces First Patient Dosed in Phase 2b RISE Study of EBX-102-02 in Irritable Bowel ...
Edit
Killeen Daily Herald
07 Jul 2026
Epicrispr Completes Enrollment and Dose Escalation in First-in-Human EPI-321 Trial for FSHD
Edit
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the ...
Nasdaq Globe Newswire 07 Jul 2026
Edit
The Daily Record - Dunn
07 Jul 2026
TIXiMED Initiates Phase 1b Multiple Ascending Dose Study of TIX100
Edit
Killeen Daily Herald
07 Jul 2026
Eradivir Doses First Influenza Patient With EV25 in Bangladesh Study
Edit
Enid News & Eagle
07 Jul 2026
Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b
Edit
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization (Rapid Dose Therapeutics Corp)
Public Technologies 07 Jul 2026
- July 7, 2026) - Rapid Dose Therapeutics Corp ... DOSE) (OTCQB ... "This agreement represents another important milestone in the evolution of our QuickStrip™ nicotine platform," said Jason Lewis, SVP of Rapid Dose Therapeutics.
Edit
Sports marketing, AI — with a dose of FOMO — take centre stage at Cannes (INMA - International Newsmedia Marketing Association)
Public Technologies 07 Jul 2026
It was a verbal launching pad for most of the week's sessions, timed precisely to match the heat dome [...] ... Attachments Original document Permalink. Disclaimer ... (noodl.
Edit
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1 (Syncona Ltd)
Public Technologies 07 Jul 2026
"Dosing the first patient in our Phase 3 trial is an important step forward in our efforts to redefine what is possible for individuals living with Gaucher disease," said Michael Parini, Chief Executive Officer.
Edit
The dangerous fantasy of cheaper cancer dosing
Great Bend Tribune 07 Jul 2026
Hospitals in India, Israel, the Netherlands, and elsewhere have recently experimented with reducing the dose size for blockbuster cancer drugs – and some patients have reportedly responded well.
Edit
Theriva™ Biologics Announces Regulatory Authorization to Proceed with a VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Theriva Biologics Inc)
Public Technologies 07 Jul 2026
- VIRAGE2 exploratory study designed to refine dosing regimen to potentially improved outcomes in a future pivotal Phase 3 clinical trial - ... of repeated VCN-01 dosing to provide clinical benefit -.
- 1
- 2
- Next page »